Interaksi Anastrozol

Anastrozol (Arimidex), golongan penghambat aromatase, memiliki 27 interaksi terdokumentasi dalam label FDA dan lembar fakta yang kami indeks: 17 mayor, 0 moderat, 0 minor, dan 10 dengan label yang melaporkan tidak ada interaksi bermakna. Setiap entri di bawah ini mengutip kalimat yang mendasarinya. Halaman obat ini adalah titik awal, bukan putusan untuk situasi Anda.

Seperti apa tampilan Anastrozol

Semua 9 versi
Tablet Anastrozol 1 mg: putih, bulat, 6 mm, dengan kode cetak Adx di satu sisi dan 1 di sisi lainnya.
Adx / 1
1 mg · putih · bulat · 6 mm
ANI
Tablet Anastrozol 1 mg: putih, bulat, 6 mm, dengan kode cetak A7.
A7
1 mg · putih · bulat · 6 mm
BluePoint
Tablet Anastrozol 1 mg: putih, bulat, 6 mm, dengan kode cetak AN di satu sisi dan 1 di sisi lainnya.
AN / 1
1 mg · putih · bulat · 6 mm
Breckenridge
Tablet Anastrozol 1 mg: putih, bulat, 6 mm, dengan kode cetak YL di satu sisi dan 111 di sisi lainnya.
YL / 111
1 mg · putih · bulat · 6 mm
Yiling

Gambar hasil render dari daftar produk pada label FDA: warna, bentuk, ukuran, dan kode cetak. 9 versi terdokumentasi dari 15 pelabel.

Interaksi dari label

Interaksi mayor (17)

  • Desogestrel dan etinilestradiolkontrasepsi oralMayor

    Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (label Anastrozol, Interaksi obat)

  • Drospirenon dan etinilestradiolkontrasepsi oralMayor

    Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (label Anastrozol, Interaksi obat)

  • EstradiolestrogenMayor

    Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (label Anastrozol, Interaksi obat)

  • Estradiol dan dienogestkontrasepsi oralMayor

    Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (label Anastrozol, Interaksi obat)

  • Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (label Anastrozol, Interaksi obat)

  • Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (label Anastrozol, Interaksi obat)

  • Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (label Anastrozol, Interaksi obat)

  • Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (label Anastrozol, Interaksi obat)

  • Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (label Anastrozol, Interaksi obat)

  • Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (label Anastrozol, Interaksi obat)

  • FulvestrantestrogenMayor

    Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (label Anastrozol, Interaksi obat)

  • Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (label Anastrozol, Interaksi obat)

  • Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (label Anastrozol, Interaksi obat)

  • Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (label Anastrozol, Interaksi obat)

  • Norgestimat dan etinilestradiolkontrasepsi oralMayor

    Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (label Anastrozol, Interaksi obat)

  • Norgestrel dan etinilestradiolkontrasepsi oralMayor

    Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (label Anastrozol, Interaksi obat)

  • Tamoksifenmodulator reseptor estrogen selektifMayor

    • Tamoxifen: Do not use in combination with ARIMIDEX. (label Anastrozol, Interaksi obat)

Tidak ada interaksi bermakna yang dilaporkan (10)

  • ApiksabanantikoagulanTanpa interaksi

    Warfarin In a study conducted in 16 male volunteers, anastrozole did not alter the exposure (as measured by C max and AUC) and anticoagulant activity (as measured by prothrombin time, activated partial thromboplastin time, and thrombin time) of both R- and S-warfarin. (label Anastrozol, Interaksi obat)

  • ArgatrobanantikoagulanTanpa interaksi

    Warfarin In a study conducted in 16 male volunteers, anastrozole did not alter the exposure (as measured by C max and AUC) and anticoagulant activity (as measured by prothrombin time, activated partial thromboplastin time, and thrombin time) of both R- and S-warfarin. (label Anastrozol, Interaksi obat)

  • BivalirudinantikoagulanTanpa interaksi

    Warfarin In a study conducted in 16 male volunteers, anastrozole did not alter the exposure (as measured by C max and AUC) and anticoagulant activity (as measured by prothrombin time, activated partial thromboplastin time, and thrombin time) of both R- and S-warfarin. (label Anastrozol, Interaksi obat)

  • DabigatranantikoagulanTanpa interaksi

    Warfarin In a study conducted in 16 male volunteers, anastrozole did not alter the exposure (as measured by C max and AUC) and anticoagulant activity (as measured by prothrombin time, activated partial thromboplastin time, and thrombin time) of both R- and S-warfarin. (label Anastrozol, Interaksi obat)

  • EdoksabanantikoagulanTanpa interaksi

    Warfarin In a study conducted in 16 male volunteers, anastrozole did not alter the exposure (as measured by C max and AUC) and anticoagulant activity (as measured by prothrombin time, activated partial thromboplastin time, and thrombin time) of both R- and S-warfarin. (label Anastrozol, Interaksi obat)

  • EnoksaparinantikoagulanTanpa interaksi

    Warfarin In a study conducted in 16 male volunteers, anastrozole did not alter the exposure (as measured by C max and AUC) and anticoagulant activity (as measured by prothrombin time, activated partial thromboplastin time, and thrombin time) of both R- and S-warfarin. (label Anastrozol, Interaksi obat)

  • FondaparinuksantikoagulanTanpa interaksi

    Warfarin In a study conducted in 16 male volunteers, anastrozole did not alter the exposure (as measured by C max and AUC) and anticoagulant activity (as measured by prothrombin time, activated partial thromboplastin time, and thrombin time) of both R- and S-warfarin. (label Anastrozol, Interaksi obat)

  • HeparinantikoagulanTanpa interaksi

    Warfarin In a study conducted in 16 male volunteers, anastrozole did not alter the exposure (as measured by C max and AUC) and anticoagulant activity (as measured by prothrombin time, activated partial thromboplastin time, and thrombin time) of both R- and S-warfarin. (label Anastrozol, Interaksi obat)

  • RivaroksabanantikoagulanTanpa interaksi

    Warfarin In a study conducted in 16 male volunteers, anastrozole did not alter the exposure (as measured by C max and AUC) and anticoagulant activity (as measured by prothrombin time, activated partial thromboplastin time, and thrombin time) of both R- and S-warfarin. (label Anastrozol, Interaksi obat)

  • WarfarinantikoagulanTanpa interaksi

    Warfarin In a study conducted in 16 male volunteers, anastrozole did not alter the exposure (as measured by C max and AUC) and anticoagulant activity (as measured by prothrombin time, activated partial thromboplastin time, and thrombin time) of both R- and S-warfarin. (label Anastrozol, Interaksi obat)

Periksa Anastrozol terhadap semua yang Anda gunakan. Tambahkan seluruh daftar Anda; setiap pasangan diperiksa sekaligus.

Buka di pemeriksa

Bukan nasihat medis. Tingkat keparahan mencerminkan kata-kata dalam label, bukan keadaan Anda. Tanda “mayor” bisa merupakan hal yang rutin di bawah pengawasan, dan tanda “minor” bisa menjadi penting pada dosis tinggi. Tanyakan kepada apoteker.